Swarm’s breakthrough T cell platform is designed to overcome these limitations by significantly enhancing the effectiveness of cancer vaccines. Swarm’s platform amplifies patients’ immune response to ...

With this donation, Bavarian Nordic has committed a total of 165,000 doses of the MVA-BN vaccine to Africa. The Company previously donated doses to the European Commission’s Health Emergency ...

– First and only disease-modifying therapy for the treatment of eligible children with MLD also receives Orphan Drug Designation and Priority Review in the Kingdom of Saudi Arabia – ...

Novartis today announced that its previously announced tender offer (the “offer”) by Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), ...

QLGN (soon to be AIxCrypto) has launched its new Web3 and crypto asset business initiatives. Following its targeted rebranding on November 12, the Company will launch the public beta of its BesTrade ...

Novartis delivers solid sales and core operating income growth with strong pipeline progress in Q3; reaffirms FY 2025 guidance En cliquant sur ce lien, vous acceptez l'utilisation de cookies sur ce ...

Gazyva/Gazyvaro versus mycophenolate mofetil shows significantly more children and young adults achieved sustained complete remission at week 52 INShore is the first global phase III study of a ...

Paris, France – October 28, 2025 - Sanofi announces that it has successfully priced its offering of $3 billion of notes across 5 tranches: $400 million fixed rate notes, due November 2027, bearing ...

Results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 in San Francisco on October 27, 2025. DynamX® bioadaptor is the first interventional ...

Protext Mobility, Inc. (OTC: TXTM), an emerging powerhouse in botanical-based biotechnology, today announced the upcoming launch of its ...

NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business ...